<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01037660</url>
  </required_header>
  <id_info>
    <org_study_id>H-23660</org_study_id>
    <nct_id>NCT01037660</nct_id>
  </id_info>
  <brief_title>Effects of Lipemia and Metformin on Endothelial Function</brief_title>
  <official_title>Effects of Lipemia and Metformin on Endothelial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eating a diet high in fat contributes to the development of atherosclerosis (hardening of the&#xD;
      arteries). Acute fat consumption increases levels of fat in the blood and temporarily reduces&#xD;
      the ability of blood vessel to dilate (open up to carry additional blood). A similar response&#xD;
      is observed during infusion of Intra-Lipid (a fat emulsion used for intravenous nutrition).&#xD;
      The present study is designed to help us understand the effects of a fat load on blood vessel&#xD;
      function. We will measure arterial dilation using non-invasive techniques before and at the&#xD;
      end of a 5-hour infusion of Intra-Lipid in healthy subjects. Subjects will then take the&#xD;
      approved drug metformin for two weeks and return for repeat studies of endothelial function&#xD;
      with Intra-Lipid infusion. We expect that metformin will help preserve the normal function of&#xD;
      blood vessels during a fat load. This study will help us understand how fat affects blood&#xD;
      vessels and therefore will advance our knowledge of the development of atherosclerosis and&#xD;
      potentially lead to improved methods to prevent and treat heart disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2005</start_date>
  <completion_date type="Actual">December 1, 2016</completion_date>
  <primary_completion_date type="Actual">December 1, 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brachial artery flow-mediated dilation</measure>
    <time_frame>6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood lipid levels</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">139</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Metformin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>Metformin 1 gram per day</description>
    <arm_group_label>Metformin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy (defined as positive urine pregnancy test)&#xD;
&#xD;
          -  Diabetes Mellitus (Clinical history or random blood glucose&gt;140 mg/dl)&#xD;
&#xD;
          -  Hypertension (Clinical history or SBP&gt;140 or DBP&gt;90 mmHg)&#xD;
&#xD;
          -  History of adverse reaction to metformin&#xD;
&#xD;
          -  Abnormal renal function (Serum creatinine&gt;1.4 mg/dl)&#xD;
&#xD;
          -  Abnormal liver function (AST or ALT greater than two times the upper limit of normal)&#xD;
&#xD;
          -  Administration of iodinated contrast within 7 days&#xD;
&#xD;
          -  History of congestive heart failure&#xD;
&#xD;
          -  Abnormal clotting parameters (INR&gt;1.5 or PTT&gt;40 sec)&#xD;
&#xD;
          -  Anemia (HCT&lt;30%)&#xD;
&#xD;
          -  Allergy to soy or egg&#xD;
&#xD;
          -  Allergy to heparin&#xD;
&#xD;
          -  The potential subject plans to perform heavy exercise in the setting of low calorie&#xD;
             intake during the period of the study such as running or competitive road or bicycle&#xD;
             racing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naomi Hamburg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>December 19, 2009</study_first_submitted>
  <study_first_submitted_qc>December 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2009</study_first_posted>
  <last_update_submitted>March 8, 2017</last_update_submitted>
  <last_update_submitted_qc>March 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston University</investigator_affiliation>
    <investigator_full_name>Naomi M Hamburg</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>endothelium</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>dietary fat</keyword>
  <keyword>insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

